Le Lézard
Classified in: Health
Subjects: PDT, DIS

InventHelp Inventor Develops Safety Accessory for the Visually Impaired (VIG-269)


PITTSBURGH, March 13, 2018 /PRNewswire/ -- "I am visually impaired, and I have dealt with walking into and tripping over things," said one of two inventors from Roper, N.C. "To avoid these dangers, I devised a way to keep myself aware of my surroundings so that I could avoid obstacles and hazards and so remain safe."

InventHelp Logo (PRNewsfoto/InventHelp)

They developed the INAV-IN HOME NAVIGATION DEVICE to alert the user to any obstacles ahead. The unit makes it possible to avoid walking into objects, which reduces the risk of trips and falls. It is designed to enhance personal safety by keeping the user out of danger. The accessory offers added peace of mind, especially when walking through unfamiliar areas. Additionally, the design keeps hands free to do other things.

The original design was submitted to the Virginia Beach office of InventHelp. It is currently available for licensing or sale to manufacturers or marketers. For more information, write Dept. 16-VIG-269, InventHelp, 217 Ninth Street, Pittsburgh, PA 15222, or call (412) 288-1300 ext. 1368. Learn more about InventHelp's Invention Submission Services at http://www.InventHelp.com.

 

SOURCE InventHelp


These press releases may also interest you

at 02:22
Swedish Orphan Biovitrum AB (publ) (Sobi®) today announced its report for the first quarter 2024 First Quarter 2024 Total revenue increased 19 per cent, 20 per cent at constant exchange rates, (CER)1, to SEK 6,256 M (5,239)Haematology revenue...

at 02:05
AstraZeneca: Revenue and EPS summary     Q1 2024 % Change $m Actual CER1 - Product Sales 12,177 15 18 - Alliance Revenue   457 59 59...

at 02:00
Indivior PLC (LSE/Nasdaq: INDV) today announced its financial results for the period ending March 31, 2024. The earnings release, investor presentation and webcast are available at www.indivior.com. The earnings release can be found at...

at 02:00
In response to the increasing complexities of the aging journey and the rising trend of...

at 02:00
PRISM BioLab, Co. Ltd. ("PRISM"), a leading discovery and development biotechnology company designing small molecule inhibitors of protein-protein interaction (PPI) targets, today announced that it has entered into a target-exclusive research and...

at 02:00
Hemogenyx Pharmaceuticals plc (LSE:HEMO), the biopharmaceutical group developing new therapies and treatments for blood...



News published on and distributed by: